| Title : Development and structure-activity relationship of tacrine derivatives as highly potent CDK2\/9 inhibitors for the treatment of cancer - Wu_2022_Eur.J.Med.Chem_242_114701 |
| Author(s) : Wu L , Liu W , Huang Y , Zhu C , Ma Q , Wu Q , Tian L , Feng X , Liu M , Wang N , Xu X , Liu X , Xu C , Qiu J , Xu Z , Zhao Q |
| Ref : Eur Journal of Medicinal Chemistry , 242 :114701 , 2022 |
| Abstract : Wu_2022_Eur.J.Med.Chem_242_114701 |
| ESTHER : Wu_2022_Eur.J.Med.Chem_242_114701 |
| PubMedSearch : Wu_2022_Eur.J.Med.Chem_242_114701 |
| PubMedID: 36054949 |
Wu L, Liu W, Huang Y, Zhu C, Ma Q, Wu Q, Tian L, Feng X, Liu M, Wang N, Xu X, Liu X, Xu C, Qiu J, Xu Z, Zhao Q (2022)
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2\/9 inhibitors for the treatment of cancer
Eur Journal of Medicinal Chemistry
242 :114701
Wu L, Liu W, Huang Y, Zhu C, Ma Q, Wu Q, Tian L, Feng X, Liu M, Wang N, Xu X, Liu X, Xu C, Qiu J, Xu Z, Zhao Q (2022)
Eur Journal of Medicinal Chemistry
242 :114701